首页> 外文期刊>The American Journal of Cardiology >Utility of Physician Selection of Cardiac Tests in a Chest Pain Unit to Exclude Acute Coronary Syndrome Among Patients Without a History of Coronary Artery Disease
【24h】

Utility of Physician Selection of Cardiac Tests in a Chest Pain Unit to Exclude Acute Coronary Syndrome Among Patients Without a History of Coronary Artery Disease

机译:医生选择心脏试验在胸痛单元中的心脏试验中的心脏试验,在没有冠状动脉疾病历史的情况下排除患者急性冠状动脉综合征

获取原文
获取原文并翻译 | 示例
           

摘要

There are few data on the utility of physician selection of cardiac tests, including no-test, in a chest pain unit (CPU) to rule out acute coronary syndrome in low-risk patients without a history of coronary artery disease. We analyzed consecutive low-risk patients admitted to our CPU between 2012 and 2014 and determined the proportion of patients selected for testing, the type of initial cardiac test selected, and the incidence of major adverse cardiac events (MACEs) at 30 days and 6 months. The study group comprised 619 patients: mean age 57 years (27 to 92), 332 women (54%), and 360 (58%) with multiple cardiac risk factors. Cardiac testing included 283 no-test (46%); 179 exercise treadmill (29 %); 113 myocardial perfusion stress scintigraphy (18%); 10% each for exercise stress echocardiography and coronary angiography. Testing was negative in 296 (88%), nondiagnostic in 30 (9%), and positive in 10 patients (3%). There were no MACEs at 30 days in any patients, and at 6 months, MACEs were 5 (1.1%). Length of stay was less in no-test than in tested patients (5.4 hours vs 9.8 hours, p 0.0001), and there was no difference in incidence of MACE at 6 months in no-test vs tested patients (2 MACEs vs 3 MACEs). Physician selection of cardiac tests, including no-test, promptly identified patients at low risk of acute coronary syndrome who could be safely and rapidly discharged from the CPU. Exclusion of cardiac testing shortened length of stay and was not associated with increase in MACE at 6 months. (C) 2018 Elsevier Inc. All rights reserved.
机译:关于医生选择的心脏试验的效用,包括无检,在胸痛单元(CPU)中,在没有冠状动脉疾病历史的情况下排除低风险患者的急性冠状动脉综合征。我们分析了2012年和2014年间CPU的连续低风险患者,并确定了所选择的患者的比例,选择的初始心脏试验类型,以及在30天和6个月的主要不良心脏事件(甘蓝)的发病率。该研究组包括619名患者:平均57岁(27至92),332名女性(54%)和360(58%),具有多种心脏风险因素。心脏试验包括283无检(46%); 179锻炼跑步机(29%); 113心肌灌注应力闪烁闪烁(18%); & 10%用于运动应激超声心动图和冠状动脉血管造影。 296(88%),30%(9%),10例患者的阳性(3%)。任何患者在30天内没有次数,6个月,迈出赛量为5(1.1%)。在无测试患者中,逗留时间较少(5.4小时与9.8小时,P& 0.0001),在无测试VS患者中6个月内没有MACE的发生率没有差异(2种次比空间3队伍)。医生选择心脏试验,包括无检,及时鉴定的患者,急性冠状动脉综合征的低风险患者可以安全,快速地从CPU释放。排除心脏测试缩短了逗留时间,并与6个月内的立柱增加无关。 (c)2018年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号